Protein Summary
May antagonize Nodal signaling and subsequent organization of axial structures during mesodermal patterning.
- ENST00000246117
- ENSP00000246117
- ENSG00000125912
- NET59
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
kinase perturbation | 0.84 | ||
transcription factor binding site profile | 0.82 | ||
tissue sample | 0.72 | ||
histone modification site profile | 0.71 | ||
disease perturbation | 0.68 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 29.43 (req: < 5)
Gene RIFs: 1 (req: <= 3)
Antibodies: 125 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 29.43 (req: >= 5)
Gene RIFs: 1 (req: > 3)
Antibodies: 125 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 4
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0